Metrics

  • citations in SCIndeks: 0
  • citations in CrossRef:0
  • citations in Google Scholar:[]
  • visits in previous 30 days:7
  • full-text downloads in 30 days:5

Contents

article: 2 from 22  
Back back to result list
2016, vol. 45, iss. 2, pp. 83-88
Cardiovascular comorbidities in hospitalized psychiatric patients with diagnoses of schizophrenic and affective disorders
aClinical Center of Serbia, Clinic for Psychiatry, Belgrade + University of Priština - Kosovska Mitrovica, Faculty of Medicine
bClinical Center of Serbia, Clinic for Psychiatry, Belgrade
cClinical Center of Serbia, Clinic for Psychiatry, Belgrade + University of Kragujevac, Faculty of Medical Sciences
dUniversity of Priština - Kosovska Mitrovica, Faculty of Medicine

emailkatarina.djokic.pjescic@gmail.com
Keywords: comorbidity; cardiovascular diseases; schizophrenic disorders; affective disorders
Abstract
A cardiovascular comorbidity (CVC) in psychiatric patients represents a simultaneous occurrence of a cardiovascular and a mental illness in the same patient regardless of the order of occurrence or of the cause and effect relationship that conjoins them. The objective was to determine the frequency and sort of the CVC in previously hospitalized patients with diagnoses of schizophrenic and affective disorders along with the differences in distribution of said disorders between the two groups of patients. Design-wise this is a retrospective study of intersections. It is based on the analytics of medical data (the history of disease along with the internal medicine consultant reviews) of the hospitalized patients in the Clinic for psychiatric disorders 'Dr. Laza Lazarević' in Belgrade during the period between November 2014 and February 2015. Patients who were involved were older than 18 and they had diagnoses of schizophrenic disorders (F20-F29) and affective disorders (F30-F39), according to diagnostic criteria in the International classification of diseases 10 (ICD-10). CVC which were previously diagnosed or registered during the examination we separated into the following groups according to ICD-10: hypertension (HTA) I10, cardiac arrhythmia (CA) I47-I49, chronic cardiomyopathy (CMP) I42-I43 and ischemic heart disease (IHD) 120-125. The two groups of patients were analyzed according with socio-demographic characteristics (gender and age range) and CVC diagnosed according to MKB-10 classification. CVC were registered in 66% of the patients diagnosed with schizophrenia and 34% of the patients with affective disorders. Hypertension was most common in both groups of patients following with cardiac arrhythmia. Cardiac arrhythmias were statistically significantly more common in patients diagnosed with schizophrenic disorders (p<0.001) compared to patients with affective disorders. The frequency of hypertension, ischemic heart disease and chronic cardiomyopathy rises with age in both groups of patients. The results of this research confirm a high degree of CVC in hospitalized patients with diagnoses of schizophrenic and affective disorders (especially cardiac arrhythmia and hypertension). A multidisciplinary team is the key for diagnosing and monitoring patients with schizophrenic and affective diseases in both primary and secondary preventions.
References
Bar, K.J. (2015) Cardiac autonomic dysfunction in patients with schizophrenia and their healthy relatives: A small review. Front Neurol, 6: 139
Beutel, M.E., Schulz, H. (2011) Comorbid psychological disorders in patients with chronic somatic diseases. Bundes. Gesund. Geseund, 54(1): 15-21
de Hert, M., Dekker, J.M., Wood, D., Kahl, K.G., Holt, R.I.G., Möller, H.-J. (2009) Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology. European Psychiatry, 24(6): 412-424
de Hert, M., Correll, C.U., Bobes, J., Cetkovich-Bakmas, M., Cohen, D., Asai, I., Detraux, J., Gautam, S., Möller, H., Ndetei, D.M., Newcomer, J.W., Uwakwe, R., Leucht, S. (2011) Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry, 10(1): 52-77
Đukić-Dejanović, S., urednik (2011) Psihijatrija. Kragujevac: Medicinski fakultet Univerziteta u Kragujevcu
Friedrich, F., Litvan, Z., Freidl, M. (2015) Somatische Komorbidität im stationär psychiatrischen Bereich – eine Analyse administrativer Daten. Neuropsychiatrie, 29(2): 71-76
Gardner-Sood, P., Lally, J., Smith, S., Atakan, Z., Ismail, K., Greenwood, K.E., Keen, A., O`Brien, C., Onagbesan, O., Fung, C., Papanastasiou, E., Eberherd, J., Patel, A., Ohlsen, R., Stahl, D., David, A., Hopkins, D., Murray, R.M., Gaughran, F. (2015) Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial. Psychological Medicine, 45(12): 2619-2629
Girardin, F. (2007) Cardiac adverse reactions associated with psychotropic drugs. Dialogues Clin Neurosci, 9(1): 92-5
Holt, R.I.G. (2015) The prevention of diabetes and cardiovascular disease in people with schizophrenia. Acta Psychiatrica Scandinavica, 132(2): 86-96
Ignaszewski, MJ., Yip, A., Fitzpatrick, S. (2015) Schizophrenia and coronary artery disease. BCMJ, 57(4):154-7
Juckel, G. (2014) Psychiatric disorders and their effects on mortality and morbidity. Versicherungsmedizin, 66(4); 184-7
Khasawneh, F.T., Shankar, G.S. (2014) Minimizing Cardiovascular Adverse Effects of Atypical Antipsychotic Drugs in Patients with Schizophrenia. Cardiology Research and Practice, 2014: 1-8
Lambert, T.J.R., Velakoulis, D., Pantelis, C. (2003) Medical comorbidity in schizophrenia. MJA, 178: 67-70
Marić, J.K. (2005) Klinička psihijatrija. Beograd: Megraf
Munoz-Calero, F.P., Sanchez, S.B., Criado, R.N., i dr. (2015) Metabolic syndrome and cardiovascular risk in patients with schizophrenia, bipolar disorder and schizoafective disorder. Nutr hosp, 32(6); 2715-7
Musselman, D.L., Evans, D.L., Nemeroff, C.B. (1998) The relationship of depression to cardiovascular disease: Epidemiology, biology, and treatment. Arch Gen Psychiatry, 55(7):580-92
North Metropolitan Area Mental Health Service (2010) Cardiac adverse effects of psychotropic medication in schizophrenia. Graylands Hospital Drug Bulletin, November Volume 2 (assessed online on April, 10th, 2016)
Pizzi, C., Santarella, L., Manfrini, O., Chiavaroli, M., i dr. (2013) Ischemic heart disease and depression: an underestimated clinical association. G Ital Cardiol (Romme), 14(7-8); 526-37
Ringen, P.A., Engh, J.A., Birkenaes, A.B., Dieset, I., Andreassen, O.A. (2014) Increased Mortality in Schizophrenia Due to Cardiovascular Disease â€' A Non-Systematic Review of Epidemiology, Possible Causes, and Interventions. Frontiers in Psychiatry, 5: 137
Robert Wood Johnson Foundation (2011) Mental disorders and medical comorbidity. Research Synthesis Report No. 21
Smith, D.J., Martin, D., McLean, G., Langan, J., Guthrie, B., Mercer, S.W. (2013) Multimorbidity in bipolar disorder and undertreatment of cardiovascular disease: a cross sectional study. BMC Medicine, 11(1): 263
Stahl, S. (2009) Essential psychopharmacology. Cambridge University Press
 

About

article language: English
document type: Scientific Paper
DOI: 10.5937/pramed1602083D
published in SCIndeks: 21/05/2017
Creative Commons License 4.0

Related records

Arhiv za farmaciju (2007)
Antidepressants pharmacology
Stepanović-Petrović Radica M.

Medicinski pregled (2006)
Types of psychological reactions in patients with lower-extremity amputations
Platiša Nedeljko, et al.

Sociologija (2011)
Television and the promotion of mental health
Milošević Ljiljana

show all [25]